Peter Hentschel - Chairman

Peter Hentschel comes from a position as Senior Vice President of Mölnlycke Health Care’s Wound Care and Surgical divisions where he worked during 1998-2006 and where he had the responsibility of up to 2500 employees worldwide. Prior to that he worked with SCA Hygiene Products where he was the Vice President of Baby Diapers - and the Incontinence Business. Peter has experience from being a board member and chairman of eight companies.

Peter Hentschel has deep and varied skills in the Health Care and Consumer markets and he has extensive experience from working internationally. He has worked both with restructuring of existing businesses and the building of new ones and he has been deeply involved in two exit processes.

Peter has a MSc in Chemical Engineering from Chalmers University of Technology and he has studied Business administration at Gothenburg University.

Ingvar Andersson

Ingvar is the CEO of Chalmersinvest since 1998, and he has more than 20 years experience of developing and investing in young companies as well as other forms of commercialization of research results. Ingvar has six years of experience in managerial positions in large multinational companies, in R&D, design, business and product development. He is a board member in LC-Tec Holding (public), Kartena (public), Parans Solar Lighting, Oxeon and Nanoxis. He is also chairman of several companies within the Chalmers group.

Ingvar is a member of the Royal Academy of Engineering Sciences and he has a PhD in mechanical engineering from Chalmers University of Technology.

Hans Dyster-Aas

Hans Dyster-Aas is the owner and Investment Manager of GUFAB that works with asset management, investments in real estate, securities and private equity. He is the former CEO of NGM Stock Exchange and he has previously held the position as Head of Securities at Carnegie Investment Bank.

Hans has a Masters of Business Administration from Lund University.

Charlotta Gummeson

Charlotta is, since 2009, Investment Manager within Life Science sector at Innovationsbron AB that works with seed capital in Sweden. Charlotta has 19 years of experience in marketing, sales and business development within the Life Sciences sector in international research-based pharmaceutical companies. Charlotta has held positions as Country Manager for Astellas, Marketing Manager GSK and worked with several therapeutic areas in Phase II to Phase IVb and medical pharmacy products throughout the value chain in the healthcare sector. She is a board member of companies within the industry. 

Charlotta is a Senior Registered nurse with specialty in Medicine and Surgery from Lund University , has studied Business administration at Gothenburg University and Strategic Brand Management at IHM Gothenburg.

Julian Nicholas

Julian Nicholas is currently working as independent consultant.

He has earlier worked on various management positions at Smith & Nephew and he has been the Managing Director of a  plant biotech start-up that was sold to Sandoz, at the time the world’s largest seed company.

During his career, Julian has managed refinancing, acquisitions and disposals and has completed countless research and development collaborations. He has also analyzed what makes successful business alliances and incorporated that learning into contract construction and management to assist value creation.

Julian has a Ph.D. from Plant Science at the University of Nottingham and an MBA from Theseus Institue in France.